Atossa Therapeutics, Inc.’s ATOS share price has surged by 5.39%, which has investors questioning if this is right time to ...

Atossa Therapeutics (NASDAQ:ATOS – Free Report) had its price objective lifted by Ascendiant Capital Markets from $7.00 to $7.25 in a research report released on Monday,Benzinga reports.

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Atos SE (GB:0DNH – Research Report), Elisa ...

Atos reported a drop in first-quarter revenue on Thursday, hit by a lower order entry in 2024 due to a sharp reduction of ...

Over the last quarter, Atos experienced a substantial share price increase of 67%, amidst a tumultuous market that saw indices like the Nasdaq enter bear market territory due to geopolitical ...

Over the last quarter, Atos experienced a substantial share price increase of 67%, amidst a tumultuous market that saw indices like the Nasdaq enter bear market territory due to geopolitical ...

(Bloomberg) -- Czech billionaire Daniel Kretinsky is facing off against David Layani’s OnePoint in his latest attempt to rescue embattled French tech company Atos SE. Atos said on Monday that it ...

Atos reported a revenue decline for the first quarter. This is due to a lower order intake in 2024 caused by a sharp decline ...

ATOSSA GENETICS ($ATOS) posted quarterly earnings results on Tuesday, March 25th. The company reported earnings of -$0.05 per share, beating estimates of -$0.06 by $0 ...

This page features the latest Atos share stories and breaking news. Assess the latest information about the Atos stock. Our team of expert financial journalists are ready to bring you today's top ATOS ...

Paris, France - March 7, 2025. – Atos SE (the “Company”) announces the implementation of a reverse stock split of the shares comprising its share capital, through the exchange of 10,000 old ...